Tela Bio Inc (TELA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,831 | -37,841 | -46,664 | -44,296 | -33,276 |
| Depreciation Amortization | 1,010 | 1,012 | 808 | 1,187 | 535 |
| Income taxes - deferred | 230 | -144 | N/A | N/A | N/A |
| Accounts receivable | -110 | -762 | -3,058 | -2,421 | -1,553 |
| Accounts payable and accrued liabilities | 141 | 482 | 11 | -884 | 1,597 |
| Other Working Capital | 4,159 | -2,013 | -620 | -3,513 | -2,018 |
| Other Operating Activity | 5,182 | -2,329 | 8,666 | 9,179 | 4,283 |
| Operating Cash Flow | $-28,219 | $-41,595 | $-40,857 | $-40,748 | $-30,432 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -448 | -989 | -599 | -872 | -627 |
| Net Acquisitions | 1,294 | 5,440 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,000 | 0 |
| Other Investing Activity | 0 | 0 | 0 | -1,000 | 0 |
| Investing Cash Flow | $846 | $4,451 | $-599 | $-1,872 | $-627 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 60,000 | N/A | N/A | 40,000 | 0 |
| Debt Repayment | -42,420 | 0 | 0 | -30,000 | 0 |
| Common Stock Issued | 11,929 | 43,426 | 46,556 | 34,469 | 585 |
| Other Financing Activity | -3,759 | -369 | -289 | -3,617 | 0 |
| Financing Cash Flow | $25,750 | $43,057 | $46,267 | $40,852 | $585 |
| Exchange Rate Effect | -217 | 28 | 164 | -144 | 11 |
| Beginning Cash Position | 52,935 | 46,994 | 42,019 | 43,931 | 74,394 |
| End Cash Position | 51,095 | 52,935 | 46,994 | 42,019 | 43,931 |
| Net Cash Flow | $-1,840 | $5,941 | $4,975 | $-1,912 | $-30,463 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,219 | -41,595 | -40,857 | -40,748 | -30,432 |
| Capital Expenditure | -448 | -989 | -611 | -872 | -627 |
| Free Cash Flow | -28,667 | -42,584 | -41,468 | -41,620 | -31,059 |